Related Experiment Video

Updated: May 3, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

9.9K

[Long-term prospective observation of patients with hypertrophic cardiomyopathy]

D V Bogdanov, I I Shaposhnik

    Klinicheskaia Meditsina
    |January 21, 2014
    PubMed

    Insights

    Hypertrophic cardiomyopathy (GCMP) progression is linked to myocardial asymmetry, not left ventricle thickening. Current therapies do not significantly alter GCMP

    Area of Science:

    • Cardiology
    • Internal Medicine
    • Genetics

    Background:

    • Hypertrophic cardiomyopathy (GCMP) is a significant cardiovascular condition.
    • Understanding GCMP progression is crucial for patient management.
    • Long-term studies are vital for characterizing disease trajectories.

    Purpose of the Study:

    • To analyze the progression of hypertrophic cardiomyopathy (GCMP) in a prospective cohort.
    • To identify predictors of GCMP progression.
    • To evaluate the impact of therapy on GCMP clinical manifestations.

    Main Methods:

    • Prospective observational study design.
    • Inclusion of patients with hypertrophic cardiomyopathy (GCMP).
    • Categorization into progressive and stable disease groups.

    Main Results:

    • 42% of patients experienced progressive GCMP, while 58% had a stable course.
    • Left ventricle thickening did not correlate with GCMP progression.
    • Manifest and extensive asymmetry of myocardial hypertrophy were key predictors of progression.
    • Dilated cardiomyopathy developed in 5.5% of nonobstructive GCMP cases.
    • Therapeutic interventions showed no significant effect on clinical outcomes.

    Conclusions:

    • Myocardial hypertrophy asymmetry is a critical factor in GCMP progression.
    • Left ventricular dimensions are not reliable indicators of disease advancement.
    • Current therapeutic strategies may require re-evaluation for their efficacy in altering GCMP course.

    More Related Videos

    Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model03:45

    Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

    Published on: August 8, 2022

    3.3K
    An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level06:02

    An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

    Published on: November 2, 2020

    6.6K

    Related Concept Videos

    Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

    Cardiomyopathy III: Hypertrophic Cardiomyopathy

    Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
    805
    Cardiomyopathy V: Interprofessional Care01:29

    Cardiomyopathy V: Interprofessional Care

    Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
    753
    Cardiomyopathy II: Dilated Cardiomyopathy01:30

    Cardiomyopathy II: Dilated Cardiomyopathy

    Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
    790
    Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

    Cardiomyopathy VII: Pre and Post Operative Nursing Management

    Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
    460
    Heart Failure II: Pathophysiology01:29

    Heart Failure II: Pathophysiology

    Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
    1.9K
    Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

    Hypertension III: Clinical Manifestations and Diagnostic Studies

    Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
    886